Chemoinformaics analysis of Tetrahydrofurospongin-2
| Molecular Weight | 330.468 | nRot | 12 |
| Heavy Atom Molecular Weight | 300.228 | nRig | 11 |
| Exact Molecular Weight | 330.219 | nRing | 2 |
| Solubility: LogS | -5.224 | nHRing | 2 |
| Solubility: LogP | 5.243 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 10 |
| nHA | 3 | APOL | 57.4798 |
| nHD | 0 | BPOL | 34.4362 |
| QED | 0.491 |
| Synth | 3.563 |
| Natural Product Likeliness | 0.885 |
| NR-PPAR-gamma | 0.872 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.98 |
| Pgp-sub | 0.016 |
| HIA | 0.016 |
| CACO-2 | -4.628 |
| MDCK | 0.0000168 |
| BBB | 0.375 |
| PPB | 0.970733 |
| VDSS | 1.55 |
| FU | 0.00962101 |
| CYP1A2-inh | 0.608 |
| CYP1A2-sub | 0.273 |
| CYP2c19-inh | 0.806 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.838 |
| CYP2c9-sub | 0.118 |
| CYP2d6-inh | 0.541 |
| CYP2d6-sub | 0.54 |
| CYP3a4-inh | 0.536 |
| CYP3a4-sub | 0.198 |
| CL | 12.877 |
| T12 | 0.454 |
| hERG | 0.055 |
| Ames | 0.012 |
| ROA | 0.978 |
| SkinSen | 0.066 |
| Carcinogencity | 0.823 |
| EI | 0.262 |
| Respiratory | 0.969 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.590182 |